Zelluna ASA
Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company has a clinical partnership with Medpace Holdings, Inc. to support the clinical trial of ZI-MA4-1 (ZIMA-101); and collaboration with Etcembly Ltd for AI-enabled TCR engineering. The company was founded in 2016 and is based in Oslo, Norway.
Zelluna ASA (ZLNA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -1.736x
Based on the latest financial reports, Zelluna ASA (ZLNA) has a cash flow conversion efficiency ratio of -1.736x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-149.03 Million) by net assets (Nkr85.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zelluna ASA - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Zelluna ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zelluna ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zelluna ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ege Seramik Sanayi ve Ticaret AS
IS:EGSER
|
-0.103x |
|
Tamawood Ltd
AU:TWD
|
0.051x |
|
Fleming Properties AB
ST:FLMNG
|
0.040x |
|
Goal Acquisitions Corp
PINK:PUCK
|
0.038x |
|
Taiwan Advance Bio-Pharmaceutical Inc.
TWO:4186
|
0.001x |
|
Samchuly Bicycle Co. Ltd
KQ:024950
|
0.163x |
|
ZINNWALD LITHIUM LS -01
F:7WW
|
N/A |
|
TOUBF
PINK:TOUBF
|
-0.160x |
Annual Cash Flow Conversion Efficiency for Zelluna ASA (2021–2025)
The table below shows the annual cash flow conversion efficiency of Zelluna ASA from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr85.86 Million | Nkr-149.03 Million | -1.736x | +12.19% |
| 2024-12-31 | Nkr82.67 Million | Nkr-163.40 Million | -1.977x | -190.92% |
| 2023-12-31 | Nkr279.39 Million | Nkr-189.83 Million | -0.679x | -82.06% |
| 2022-12-31 | Nkr449.35 Million | Nkr-167.69 Million | -0.373x | -75.92% |
| 2021-12-31 | Nkr593.15 Million | Nkr-125.83 Million | -0.212x | -- |